Safety and Efficacy of 0.1% Nepafenac versus 1% Prednisolone Acetate Eye Drops after Laser Peripheral Iridotomy: A Prospective, Randomized Trial.

[1]  J. Schuman,et al.  SALT Trial: Steroids after Laser Trabeculoplasty: Impact of Short-Term Anti-inflammatory Treatment on Selective Laser Trabeculoplasty Efficacy. , 2019, Ophthalmology.

[2]  Savleen Kaur,et al.  Steroid-induced Glaucoma: An Avoidable Irreversible Blindness , 2017, Journal of current glaucoma practice.

[3]  Karun S. Arora,et al.  Use of Various Glaucoma Surgeries and Procedures in Medicare Beneficiaries from 1994 to 2012. , 2015, Ophthalmology.

[4]  Viney Gupta,et al.  Steroid-induced glaucoma and childhood blindness , 2015, British Journal of Ophthalmology.

[5]  M. Nagpal,et al.  Topical nepafenac 0.1% alone versus prednisolone acetate 1% as postoperative anti-inflammatory agents in small gauge vitrectomy , 2014, Indian journal of ophthalmology.

[6]  J. Numaga,et al.  Nepafenac 0.1% versus fluorometholone 0.1% for preventing cystoid macular edema after cataract surgery , 2011, Journal of cataract and refractive surgery.

[7]  D. Friedman,et al.  Long-term outcomes in fellow eyes after acute primary angle closure in the contralateral eye. , 2006, Ophthalmology.

[8]  Douglas A Jabs,et al.  Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. , 2005, American journal of ophthalmology.

[9]  C. Laurell,et al.  Effects of dexamethasone, diclofenac, or placebo on the inflammatory response after cataract surgery , 2002, The British journal of ophthalmology.

[10]  P. Foster,et al.  The definition and classification of glaucoma in prevalence surveys , 2002, The British journal of ophthalmology.

[11]  T. Aung,et al.  Acute primary angle closure in an Asian population: long-term outcome of the fellow eye after prophylactic laser peripheral iridotomy. , 2000, Ophthalmology.

[12]  J. Yanni,et al.  Nepafenac, a Unique Nonsteroidal Prodrug with Potential Utility in the Treatment of Trauma-Induced Ocular Inflammation: II. In Vitro Bioactivation and Permeation of External Ocular Barriers , 2000, Inflammation.

[13]  B. Fleck,et al.  Comparison of the efficacy of diclofenac and betamethasone following strabismus surgery , 1997, The British journal of ophthalmology.

[14]  R. Leblanc,et al.  Uveitis in association with topically administered corticosteroid. , 1970, American journal of ophthalmology.

[15]  M. F. Armaly.  STATISTICAL ATTRIBUTES OF THE STEROID HYPERTENSIVE RESPONSE IN THE CLINICALLY NORMAL EYE. I. THE DEMONSTRATION OF THREE LEVELS OF RESPONSE. , 1965, Investigative ophthalmology.

[16]  B. Becker,et al.  INTRAOCULAR PRESSURE RESPONSE TO TOPICAL CORTICOSTEROIDS. , 1965, Investigative ophthalmology.

[17]  R. Lowe.  ACUTE ANGLE-CLOSURE GLAUCOMA*† , 1962, The British journal of ophthalmology.

[18]  K. Walter,et al.  Management of Ocular Inflammation following Routine Cataract Surgery— Topical Corticosteroid (Prednisolone) versus Topical Non-steroidal (Bromfenac) , 2011 .